These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2389260)

  • 1. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine.
    Buccafusco JJ; Heithold DL; Chon SH
    Toxicol Lett; 1990 Aug; 52(3):319-29. PubMed ID: 2389260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition.
    Buccafusco JJ; Li W
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):85-98. PubMed ID: 1352646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine.
    Buccafusco JJ; Graham JH; Aronstam RS
    Pharmacol Biochem Behav; 1988 Feb; 29(2):309-13. PubMed ID: 3362926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman.
    Buccafusco JJ; Graham JH; VanLingen J; Aronstam RS
    Neurotoxicol Teratol; 1989; 11(1):39-44. PubMed ID: 2725439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor.
    Buccafusco JJ; Aronstam RS; Graham JH
    Toxicol Lett; 1988 Sep; 42(3):291-9. PubMed ID: 3176058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine protection from soman and echothiophate toxicity in mice.
    Aronstam RS; Smith MD; Buccafusco JJ
    Life Sci; 1986 Dec; 39(22):2097-102. PubMed ID: 3784771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trihexyphenidyl enhances physostigmine prophylaxis against soman poisoning in guinea pigs.
    Lim DK; Hoskins B; Ho IK
    Fundam Appl Toxicol; 1991 Apr; 16(3):482-9. PubMed ID: 1855620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure.
    Anderson DR; Harris LW; Lennox WJ; Solana RP
    Drug Chem Toxicol; 1991; 14(1-2):1-19. PubMed ID: 1889370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication.
    von Bredow J; Corcoran K; Maitland G; Kaminskis A; Adams N; Wade J
    Fundam Appl Toxicol; 1991 Nov; 17(4):782-9. PubMed ID: 1778364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet composition modifies the toxicity of repeated soman exposure in rats.
    Langston JL; Myers TM
    Neurotoxicology; 2011 Dec; 32(6):907-15. PubMed ID: 21641933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication.
    Harris LW; Talbot BG; Lennox WJ; Anderson DR; Solana RP
    Drug Chem Toxicol; 1991; 14(3):265-81. PubMed ID: 1935706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse.
    Buccafusco JJ; Aronstam RS
    J Pharmacol Exp Ther; 1986 Oct; 239(1):43-7. PubMed ID: 3761196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of physostigmine and soman using taste aversion and nociception.
    Romano JA; King JM; Penetar DM
    Neurobehav Toxicol Teratol; 1985; 7(3):243-9. PubMed ID: 4033865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice against soman by pretreatment with eptastigmine and physostigmine.
    Tuovinen K; Hänninen O
    Toxicology; 1999 Dec; 139(3):233-41. PubMed ID: 10647923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor.
    Buccafusco JJ; Aronstam RS
    Toxicol Lett; 1987 Sep; 38(1-2):67-76. PubMed ID: 2820088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation.
    Philippens IH; Vanwersch RA; Groen B; Olivier B; Bruijnzeel PL; Melchers BP
    Toxicol Sci; 2000 Jan; 53(1):84-91. PubMed ID: 10653525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by clonidine from the cardiovascular changes and lethality following soman administration in the rat: role of brain acetylcholine.
    Magrí V; Buccafusco JJ; Aronstam RS
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):464-73. PubMed ID: 3188010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
    Harris LW; Anderson DR; Pastelak AM; Vanderpool B
    Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman.
    Capacio BR; Byers CE; Merk KA; Smith JR; McDonough JH
    Drug Chem Toxicol; 2004 May; 27(2):95-110. PubMed ID: 15198070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.